Palantir faces UK contract threat, as lawmakers label firm a weakness

The UK Science, Innovation and Technology Committee labeled the government's reliance on Palantir an unacceptable point of weakness.

Lawmakers highlighted risks to national digital sovereignty and potential vendor lock-in regarding the firm's £330 million National Health Service (NHS) contract.

The report urges the government to consider exercising a break clause in the NHS agreement.

Committee members recommended a new strategy to diversify technology suppliers and reduce dependence on the U.S. data analytics firm.

The report cited a clear mismatch with UK values, specifically noting the political views of co-founder Peter Thiel.

This parliamentary scrutiny increases pressure on Palantir’s expanding role within critical UK public services.